Jiang X.; Wu Q.; Opoku Y.K.; Zou Y.; Wang D.; Hu C.; Ren G.
(John Wiley and Sons Inc, 2022)
Elevated levels of circulating fibroblast growth factor 21 (FGF21) have been reported in patients with hyperuricemia. However, the effect of FGF21 in hyperuricemic nephropathy (HN) remains unexplored. Here, we investigated ...